Market-Moving News for March 4th

AKRO: 99% | Akero Therapeutics Released Preliminary Topline Week 96 Results From HARMONY Phase 2B Study Of Efruxifermin For Pre-Cirrhotic Metabolic Dysfunction-associated Steatohepatitis, Fibrosis Stage 2 Or 3

SMCI: 16% | Super Micro Computer shares are trading higher the S&P Dow Jones Indices announced that the company is set to join the S&P 500. Goldman Sachs initiated coverage on the stock with a Neutral rating and announced a $941 price target.

QNRX: 169% | Quoin Pharmaceuticals Announces FDA Clearance To Recruit Teen Subjects Into Both Ongoing Netherton Syndrome Clinical Studies